Amneal Pharmaceuticals (NASDAQ:AMRX) Now Covered by The Goldman Sachs Group
The Goldman Sachs Group began coverage on shares of Amneal Pharmaceuticals (NASDAQ:AMRX – Get Free Report) in a research note issued to investors on Friday, MarketBeat reports. The brokerage set a “buy” rating and a $12.00 price target on the stock. The Goldman Sachs Group’s target price would indicate a potential upside of 57.48% from […]
The Goldman Sachs Group began coverage on shares of Amneal Pharmaceuticals (NASDAQ:AMRX – Get Free Report) in a research note issued to investors on Friday, MarketBeat reports. The brokerage set a “buy” rating and a $12.00 price target on the stock. The Goldman Sachs Group’s target price would indicate a potential upside of 57.48% from […]
